Index of reports
> Cases with Disease Progression (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Metolazone where reactions include disease progression. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Metolazone side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-06-08
Patient: male, weighing 114.6 kg (252.1 pounds)
Reactions: Blood Creatinine Increased, Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Furosemide
Dosage: 120 mg, tid
Administration route: Oral
Start date: 2011-12-26
End date: 2012-03-29
Blinded Aliskiren
Dosage: code not broken
Administration route: Oral
Start date: 2011-12-21
Bumetanide
Dosage: 8 mg, unk
Start date: 2011-12-03
End date: 2011-12-13
Enalapril Maleate
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-07-08
End date: 2011-11-30
Enalapril Maleate
Dosage: code not broken
Administration route: Oral
Start date: 2011-12-21
Furosemide
Dosage: unk
Start date: 2011-12-13
Metolazone
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-12-05
End date: 2011-12-08
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-07-08
End date: 2011-11-30
Bumetanide
Dosage: 2 mg x 4
Start date: 2011-12-03
End date: 2011-12-13
Furosemide
Dosage: 120 + 80 + 120 mg
Start date: 2011-12-14
End date: 2011-12-20
Blinded Aliskiren
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-07-08
End date: 2011-11-30
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Start date: 2011-12-21
Other drugs received by patient: Spironolactone; Metoprolol; Hydrochlorothiazde TAB; Warfarin Sodium; Spironolactone; Spironolactone; Digoxin; Digoxin; Simvastatin
Possible Metolazone side effects in male
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-24
Patient: male, weighing 114.6 kg (252.1 pounds)
Reactions: Blood Creatinine Increased, Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Aliskiren
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-07-08
End date: 2011-11-30
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Start date: 2011-12-21
Metolazone
Dosage: 2.5 mg, unk
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-12-05
End date: 2011-12-08
Blinded Aliskiren
Dosage: code not broken
Administration route: Oral
Start date: 2011-12-21
Furosemide
Dosage: 120 mg, tid
Administration route: Oral
Start date: 2011-12-26
End date: 2012-03-29
Bumetanide
Dosage: 8 mg, unk
Start date: 2011-12-03
End date: 2011-12-13
Furosemide
Dosage: unk
Start date: 2011-12-13
Enalapril Maleate
Dosage: code not broken
Administration route: Oral
Start date: 2011-12-21
Furosemide
Dosage: 120 + 80 + 120 mg
Start date: 2011-12-14
End date: 2011-12-20
Enalapril Maleate
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-07-08
End date: 2011-11-30
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure
Start date: 2011-07-08
End date: 2011-11-30
Other drugs received by patient: Hydrochlorothiazide; Spironolactone; Digoxin; Digoxin; Simvastatin; Warfarin Sodium; Metoprolol Tartrate
Possible Metolazone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-29
Patient: male, weighing 93.0 kg (204.6 pounds)
Reactions: Cardiac Failure Chronic, Coronary Artery Disease, Concomitant Disease Progression, Hypokalaemia, Disease Progression, Ventricular Tachycardia, Hypomagnesaemia, Thrombocytopenia, Hepatic Cirrhosis, Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Enalapril Maleate
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2011-05-01
Metolazone
Dosage: 5 mg, every 10 days
Indication: Cardiac Failure Congestive
Start date: 2011-10-07
Furosemide
Dosage: 80 mg qam and 40 mg qpm
Indication: Cardiac Failure Congestive
Start date: 2006-01-01
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2011-05-01
Valsartan
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2011-05-01
Other drugs received by patient: Aspirin; Carvedilol; Micardis; Niaspan; Crestor; Micardis
Possible Metolazone side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-23
Patient: male, weighing 108.8 kg (239.4 pounds)
Reactions: Cardiac Failure Chronic, Ventricular Tachycardia, Hypomagnesaemia, Coronary Artery Disease, Concomitant Disease Progression, Hypokalaemia, Disease Progression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Furosemide
Dosage: 80 mg qam and 40 mg qpm
Indication: Cardiac Failure Congestive
Start date: 2006-01-01
Metolazone
Dosage: 5 mg every 10 drop
Indication: Cardiac Failure Congestive
Start date: 2011-10-07
Enalapril Maleate
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2011-05-01
Potassium Supplements
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2011-05-01
Valsartan
Dosage: code not broken
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2011-05-01
Other drugs received by patient: Crestor; Micardis; Niaspan; Micardis; Carvedilol; Aspirin
Possible Metolazone side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-05
Patient: 52 year old female, weighing 52.0 kg (114.4 pounds)
Reactions: Cardiac Failure, Concomitant Disease Progression, Disease Progression, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-07-13
End date: 2011-07-14
Imatinib Mesylate
Dosage: 400 mg, qd
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2011-05-12
End date: 2011-07-12
Metolazone
Possible Metolazone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-25
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Cardiac Failure, Renal Failure Acute, Disease Progression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-07-13
End date: 2011-07-15
Imatinib Mesylate
Dosage: 400 mg, qd
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2011-05-11
End date: 2011-07-05
Metolazone
Dosage: 2.5 mg, qd
Administration route: Oral
Start date: 2011-07-02
Other drugs received by patient: Tracleer; Spironolactone; Remodulin; Revatio; Furosemide
Possible Metolazone side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-25
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Cardiac Failure, Renal Failure Acute, Disease Progression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: 400 mg, qd
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2011-05-11
End date: 2011-07-05
Imatinib Mesylate
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-07-13
End date: 2011-07-15
Metolazone
Dosage: 2.5 mg, qd
Administration route: Oral
Start date: 2011-07-02
Other drugs received by patient: Tracleer; Revatio; Furosemide; Remodulin; Spironolactone
Possible Metolazone side effects in female
Reported by a physician from United States on 2011-10-07
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Cardiac Failure, Disease Progression, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Metolazone
Dosage: 2.5 mg, qd
Administration route: Oral
Start date: 2011-07-02
Imatinib Mesylate
Dosage: 400 mg, qd
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2011-05-12
End date: 2011-07-14
Electrolyte Solutions
Other drugs received by patient: Tracleer; Revatio; Furosemide; Remodulin; Spironolactone
Possible Metolazone side effects in female
Reported by a physician from United States on 2011-10-07
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Cardiac Failure, Disease Progression, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Electrolyte Solutions
Metolazone
Dosage: 2.5 mg, qd
Administration route: Oral
Start date: 2011-07-02
Imatinib Mesylate
Dosage: 400 mg, qd
Administration route: Oral
Indication: Pulmonary Arterial Hypertension
Start date: 2011-05-12
End date: 2011-07-14
Other drugs received by patient: Tracleer; Remodulin; Spironolactone; Revatio; Furosemide
Possible Metolazone side effects in 52 year old female
Reported by a physician from United States on 2011-10-03
Patient: 52 year old female, weighing 52.0 kg (114.4 pounds)
Reactions: Cardiac Failure, Concomitant Disease Progression, Disease Progression, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2011-05-11
End date: 2011-07-13
Metolazone
Imatinib Mesylate
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2011-07-13
End date: 2011-07-15
|